Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Rosuvastatin vs Low-dose Rosuvastatin + Ezetimibe in Elderly ASCVD
NCT04826354Phase 4Completed
- Sponsor
- Korea University Anam Hospital
- Start
- Aug 2021
- Primary completion
- May 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin, ezetimibe in atherosclerotic cardiovascular disease (ASCVD), hypercholesterolemia, sponsored by Korea University Anam Hospital. Started Aug 2021; status: completed.
02
Drugs
rosuvastatinezetimibe
03
Conditions
atherosclerotic cardiovascular disease (ASCVD)hypercholesterolemia
Beyond the preview
Go deeper on NCT04826354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04826354.